Authors: Rutgeerts, P D'Haens, G Targan, S Vasiliauskas, E Hanauer, SB Present, DH Mayer, L Van Hogezand, RA Braakman, T DeWoody, KL Schaible, TF Van Deventer, SJH

Citation: P. Rutgeerts et al., Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease, GASTROENTY, 117(4), 1999, pp. 761-769